Case C-201/19 P: Judgment of the Court (First Chamber) of 27 June 2024 – Servier SAS, Servier Laboratories Ltd, Les Laboratoires Servier SAS v European Commission, European Federation of Pharmaceutical Industries and Associations (EFPIA) (Appeal – Competition – Pharmaceutical products – Market for perindopril – Article 101 TFEU – Agreements, decisions and concerted practices – Potential competition – Restriction of competition by object – Strategy to delay the market entry of generic versions of perindopril – Patent dispute settlement agreement – Duration of the infringement – Concept of a single infringement – Annulment or reduction of the fine)

market access patent sanction (eu) cartel cardiovascular disease alternative dispute resolution restriction on competition generic drug

Authors

Citation: Case C-201/19 P: Judgment of the Court (First Chamber) of 27 June 2024 – Servier SAS, Servier Laboratories Ltd, Les Laboratoires Servier SAS v European Commission, European Federation of Pharmaceutical Industries and Associations (EFPIA) (Appeal – Competition – Pharmaceutical products – Market for perindopril – Article 101 TFEU – Agreements, decisions and concerted practices – Potential competition – Restriction of competition by object – Strategy to delay the market entry of generic versions of perindopril – Patent dispute settlement agreement – Duration of the infringement – Concept of a single infringement – Annulment or reduction of the fine) (OJ C, C/2024/4828, 12.08.2024, ELI: http://data.europa.eu/eli/C/2024/4828/oj )